New European Survey Of ITP: Insight Into Treatment Experience For Patients ...
ZUG, Switzerland, June 10, 2011 /PRNewswire/ --
Amgen announced today the results of a new European survey of people suffering from a rare blood disorder called immune thrombocytopenia (ITP) shows that one in four feels the impact of the condition on their daily lives is severe, causing them anxiety and concern. ITP is a rare, serious and often chronic immune disorder characterised by low platelet counts in the blood.
The survey also shows that two-thirds of people in the six countries surveyed would like to have more healthcare professional advice and expert information than they are currently receiving, to help them better manage their condition.
Adult chronic ITP affects an estimated 2.0 per 100,000 patients in the European Union (EU), (1,2) and is a rare and serious autoimmune disorder characterised by low platelet counts in the blood (thrombocytopenia), which can lead to severe bleeding events. ITP occurs when immune system cells (specialised lymphocytes) produce antibodies that cause the destruction of platelets in the spleen and other organs. The specific cause of ITP is unknown and in most adults it is a chronic condition.
Notes to Editors About the ITP Patient Experience Survey(3) - The survey was conducted by Kantar Health in 158 ITP patients in six European countries: UK, Germany, France, Italy, Spain and the Netherlands. - The data was collected via a semi-structured questionnaire of 15 minutes duration with a mixture of telephone and face-to-face interviews and online responses, depending on the country. - Nearly three quarters of the patients were female and their mean age was 47 years old. - Around 70 percent of respondents had been diagnosed around four or more years ago, with the remainder diagnosed in the last three years. - The survey was sponsored by Amgen (Europe) GmbH. Patient Treatment Experience Findings(3) - Sixty percent of patients surveyed were being prescribed or had been prescribed steroids. - Forty percent of patients had received at least three or more different therapies over time, suggesting that patients are not being managed on one therapy alone. - Nearly 80 percent of patients felt that their treatment could be improved by at least one factor; citing efficacy, fewer side effects and less frequent administration as the main areas. - Patients believed that one of the most important factors about a treatment is if it has a proven safety record and is effective at maintaining target platelet count over time. Access to ITP Information Findings(3) - Most were satisfied with the support they had received from physicians, stating that their diagnosis was quick, often within three months, that they received enough information about their condition and felt they were given strong emotional support. - When patients asked their physicians about treatment options, older therapies such as steroids and splenectomy were most commonly discussed. When patients actively sought more information about ITP from other sources, they were most keen to learn about treatment options and specifically newer therapies. - In terms of where patients found their information, more than half came from the internet, suggesting that ITP patients are keen to search online and there are opportunities to support them further through this medium.
Itp Blood Disease - News
The following year, after further testing, she learned she had ITP, idiopathic thrombocytopenic purpura, a blood disease similar to hemophilia, in which her platelet count hovers around 50. (Normal platelet counts are in the hundreds of thousands.
Abagail was diagnosed with a blood disorder called ITP (idiopathic thrombocytopenic purpura), which is a low-platelet condition from an unknown origin. Abagail's outward symptoms were bruising and broken blood vessels on her cheeks.
Amgen announced today the results of a new European survey of people suffering from a rare blood disorder called immune thrombocytopenia (ITP) shows that one in four feels the impact of the condition on their daily lives is severe, causing them anxiety
Idiopathic thrombocytopenic purpura, ITP, is an illness of children and adults. With children, the illness usually follows a viral infection. Children almost always are over it in three months. In adults, it comes on more surreptitiously and persists
ITP Blood Disorder : Blood
ITP Blood Disorder
June 14, 2011 in Blood Disorder , Blood, Health Complications and Treatment
Many people suffer from several bleeding disorders and Idiopathic thrombocytopenia purpura (ITP) is one such disorder that commonly occurs under the skin surface. It is very hard to detect this bleeding disorder and it only gets revealed during the infection itself. People suffering from ITP blood disorder may experience flu and cold especially pregnant women are more effected by this. Read on to know more about this blood disorder in more detail.
How to Identify?
ITP blood disorder generally occurs when there is a decrease in the platelet count. Platelets play a major role in controlling the blood flow in the body and decrease in their count can lead to several other complications as well. People suffering from an abnormal platelet count may commonly experience certain symptoms such as internal bleeding and purple colored skin bruises.
Features Make sure you consult a doctor immediately if you observe any of the symptoms mentioned above as this helps in preventing further complications. Treatment for this condition generally involves certain diagnostic tests. It also depends on the patient’s preference and medical history. This condition can be treated with the help of steroids, controlling infections and by removing the spleen.
How to Prevent Complications? People suffering from this condition and experiencing frequent nose bleeds should see to it that they cover themselves properly by wearing a protective and proper head gear. There are chances for people suffering from this condition to experience excessive bleeding and this can be avoided by taking aspirin under a doctor’s supervision.
Itp Blood Disease - Bookshelf
Blood diseases of infancy and childhood, in the tradition of C.H. Smith
Hippocrates may have been the first to describe ITP, but this disease was ... Harrington et a\.m transfused 10 normal persons with blood from patients with ...The treatment of modern Western medical diseases with Chinese medicine, a textbook & clinical manual
Like many other autoimmune diseases, the chronic, adult form of ITP seems to ... In the acute type, blood tests show a sharp reduction in platelet count and ...Molecular Hematology
Idiopathic thrombocytopenic purpura as a model of autoimmune blood disease ITP is usually an acquired disorder in which platelets are coated (opsonized) ...Transfusion Medicine and Hemostasis, Clinical and Laboratory Aspects
A history of poor growth, frequent infections, family history of blood disease or other unusual findings are also not consistent with ITP, ...Smith's Blood diseases of infancy and childhood
Finally, if ITP extends beyond 6 months in a continuous or recurrent fashion, the disorder then shifts by definition from acute to chronic ITP and a new set ...Walkthroughs Directory
ITP, petechiae, and purpura
In ITP, the blood doesn?t clot as it should, which can cause bleeding. A person who has ITP may have bleeding that results in tiny red or purple dots on the skin. ...
ITP Blood Disease: What is it? What is the Connection to ...
ITP Blood Disease and Glutathione: What is the Connection
Idiopathic thrombocytopenic purpura - Wikipedia, the free ...
ITP was first described by the German physician Paul Gottlieb Werlhof in 1735,[2] ... 2 to 1, which has resulted in ITP being designated an orphan disease.[10] ...
Idiopathic thrombocytopenic purpura (ITP) overview
Idiopathic thrombocytopenic purpura (ITP) is a bleeding condition in which the blood doesn't clot as it should. This is due to a low number of blood cell fragments ...
Bloodindex - Immune Thrombocytopenic Purpura (ITP)
Immune thrombocytopenic purpura (ITP) is an autoimmune disease or a disorder of the blood, which occurs when antibodies from the immune system attack the body's ...